IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,697,404 | +8.6% | 147,650 | -1.8% | 0.48% | +10.9% |
| Q2 2023 | $6,166,809 | +15.8% | 150,300 | +0.9% | 0.43% | +8.6% |
| Q1 2023 | $5,323,830 | -5.4% | 148,960 | 0.0% | 0.40% | -8.9% |
| Q4 2022 | $5,626,219 | -14.7% | 148,960 | -0.1% | 0.44% | -20.4% |
| Q3 2022 | $6,593,000 | +19.3% | 149,070 | -0.1% | 0.55% | +25.4% |
| Q2 2022 | $5,525,000 | -0.4% | 149,250 | -0.3% | 0.44% | +17.2% |
| Q1 2022 | $5,547,000 | +20.8% | 149,745 | -0.8% | 0.37% | +24.7% |
| Q4 2021 | $4,593,000 | -12.3% | 150,935 | -3.4% | 0.30% | -14.6% |
| Q3 2021 | $5,239,000 | -16.6% | 156,200 | -0.8% | 0.35% | -22.9% |
| Q2 2021 | $6,282,000 | -10.8% | 157,490 | +0.6% | 0.45% | -18.1% |
| Q1 2021 | $7,042,000 | -21.0% | 156,620 | -0.7% | 0.55% | -23.3% |
| Q4 2020 | $8,916,000 | +6.0% | 157,685 | -11.1% | 0.72% | -14.7% |
| Q3 2020 | $8,415,000 | -19.8% | 177,350 | -0.3% | 0.85% | -25.6% |
| Q2 2020 | $10,491,000 | +23.1% | 177,935 | -1.3% | 1.14% | +2.2% |
| Q1 2020 | $8,522,000 | -22.8% | 180,245 | -1.3% | 1.11% | -3.0% |
| Q4 2019 | $11,033,000 | +0.9% | 182,629 | +0.0% | 1.15% | -7.0% |
| Q3 2019 | $10,938,000 | -7.4% | 182,575 | -0.7% | 1.23% | -9.1% |
| Q2 2019 | $11,818,000 | -21.0% | 183,880 | -0.2% | 1.36% | -22.9% |
| Q1 2019 | $14,961,000 | +12.0% | 184,315 | -25.4% | 1.76% | -4.1% |
| Q4 2018 | $13,361,000 | +3.8% | 247,156 | -1.0% | 1.83% | +14.5% |
| Q3 2018 | $12,872,000 | +22.8% | 249,546 | -0.8% | 1.60% | +12.7% |
| Q2 2018 | $10,478,000 | -5.9% | 251,456 | -0.5% | 1.42% | -4.4% |
| Q1 2018 | $11,139,000 | +287.4% | 252,706 | +342.2% | 1.49% | +262.0% |
| Q4 2017 | $2,875,000 | -7.9% | 57,151 | -7.1% | 0.41% | -14.6% |
| Q3 2017 | $3,120,000 | -2.9% | 61,547 | -2.5% | 0.48% | -9.8% |
| Q2 2017 | $3,212,000 | +25.0% | 63,142 | -1.2% | 0.53% | +22.2% |
| Q1 2017 | $2,569,000 | -14.2% | 63,911 | +2.1% | 0.44% | -16.5% |
| Q4 2016 | $2,994,000 | +29.7% | 62,596 | -0.7% | 0.52% | +24.3% |
| Q3 2016 | $2,309,000 | +55.3% | 63,031 | -1.3% | 0.42% | +49.5% |
| Q2 2016 | $1,487,000 | -34.2% | 63,831 | +14.4% | 0.28% | -38.2% |
| Q1 2016 | $2,260,000 | -31.6% | 55,800 | +4.6% | 0.46% | -34.8% |
| Q4 2015 | $3,303,000 | – | 53,331 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |